RJH Biosciences is a biotechnology company based out of Edmonton, Alberta, Canada. We develop novel transfection reagents and delivery systems that transport different types of nucleic acids to a range of human cells and cell lines.

We develop value-added products in two commercial segments, as transfection reagents for biomedical R&D enterprise and as nucleic acid delivery vehicles for preclinical and clinical applications. We also offer R&D service contracts relating to transfection technologies in order to fully support our customers and their novel nucleic acid technologies. 

The company was founded by Dr. Hasan Uludag, Dr. Remant K.C, and Dr. Juliana Valencia-Serna in December 2016 based on a long history of technical expertise in transfection reagent and delivery vehicle development at the University of Alberta.